Medtech in a Minute: BD Pounces on Critical Care Opportunity, and More

The medtech news you need. In one minute or less.

Amanda Pedersen

June 7, 2024

1 Min Read
Medtech in a Minute graphic for weekly feature of top medtech news of the week.

BD Pounces on Critical Care Opportunity

Edwards Lifesciences had planned to spin off its critical care business to focus on its structural heart business. BD saw that news as an opportunity to expand its smart connected care portfolio and become a leader in advanced monitoring technologies. BD said earlier this week it will pay $4.2 billion for the business.

Giving up the Grail

Grail is expected to become an independent public company on June 24. Illumina plans to spin off the cancer blood testing company, which expects to trade on Nasdaq as “GRAL.” This will bring to an end a chapter of Illumina's history in which the company forged ahead with an $8 billion acquisition despite the deal being under investigation by antitrust regulators. Illumina will, however, maintain a minority share of 14.5% in Grail.

Steris Makes Workforce Cuts

Adding to a growing list of companies making workforce cuts in 2024, Steris said it will eliminate “less than 300 positions” to increase profitability and efficiency. The layoffs amount to about 1.7% of the company's global workforce of 18,000.

About the Author(s)

Amanda Pedersen

Amanda Pedersen is a veteran journalist and award-winning columnist with a passion for helping medical device professionals connect the dots between the medtech news of the day and the bigger picture. She has been covering the medtech industry since 2006.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like